Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2200060976Phase 4Not yet recruiting
Phase 4 trial of esketamine (3 arms), sponsored by Hunan Children's Hospital. Primary endpoints: Ramsay sedation score and Steward awakening score. Planned start Jun 2022; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2200060976.